Abstract: A method for producing stable and bioavailable Actinidia deliciosa powder from kiwifruit, including drying kiwifruit pulp to form dried pulp, separately drying kiwifruit skin to form a dried skin, measuring the insoluble fiber content of the dried pulp and the dried skin, and making a blend by adding the dried skin to the dried pulp in an amount to obtain an insoluble fiber content of 10-15% in the blend. The Actinidia deliciosa powder is free of artificial additives, anti-caking agents, or flow agents and has a moisture content of less than about 2.5%.
Abstract: An improved manufacturing process produces microcrystalline hydroxyapatite with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
Type:
Grant
Filed:
April 20, 2018
Date of Patent:
August 18, 2020
Assignee:
Waitaki Biosciences
Inventors:
Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
Abstract: An improved manufacturing process produces microcrystalline hydroxyapatite with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
Type:
Application
Filed:
April 20, 2018
Publication date:
August 23, 2018
Applicant:
Waitaki Biosciences
Inventors:
Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
Abstract: An improved manufacturing process produces microcrystalline hydroxyapatrte with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
Type:
Grant
Filed:
September 4, 2014
Date of Patent:
May 22, 2018
Assignee:
WAITAKI BIOSCIENCES
Inventors:
Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
Abstract: An improved manufacturing process produces microcrystalline hydroxyapatrte with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
Type:
Application
Filed:
September 4, 2014
Publication date:
August 11, 2016
Applicant:
Waitaki Biosciences
Inventors:
Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite